Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
The company dispatched the first batch of essential medicines worth US $ 30,000 to Ukraine through its embassy in New Delhi
Subscribe To Our Newsletter & Stay Updated
